The Zika loopholes

March 25, 2016 - Last week, the Senate voted to add Zika to the list of neglected diseases for which pharmaceutical companies and other entities doing research and development for neglected diseases can receive a fast-track review for another product from the Food and Drug Administration. At first glance this seems like an apt move—the program was designedto encourage the development of treatments and vaccines for neglected diseases, and Zika is a disease for which there are currently no treatments or vaccines.